Companies: 10,638     total market cap: โ‚น12170.341 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Sarepta Therapeutics
SRPT
#4401
Rank
โ‚น209.54 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น2,000
Share price
-2.45%
Change (1 day)
-81.30%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น76.45 Billion

According to Sarepta Therapeutics 's latest financial reports the company has โ‚น76.45 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sarepta Therapeutics - Cash on Hand chart (from 1997 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น116.22 B-16.71%
2023-12-31โ‚น139.54 B-15.23%
2022-12-31โ‚น164.62 B4.53%
2021-12-31โ‚น157.48 B11.08%
2020-12-31โ‚น141.77 B76.76%
2019-12-31โ‚น80.20 B-2.29%
2018-12-31โ‚น82.08 B19.14%
2017-12-31โ‚น68.89 B218.99%
2016-12-31โ‚น21.59 B68.85%
2015-12-31โ‚น12.79 B-4.04%
2014-12-31โ‚น13.33 B-16.03%
2013-12-31โ‚น15.87 B54.5%
2012-12-31โ‚น10.27 B386.75%
2011-12-31โ‚น2.11 B40.25%
2010-12-31โ‚น1.50 B-32.81%
2009-12-31โ‚น2.23 B306.16%
2008-12-31โ‚น0.55 B-43.96%
2007-12-31โ‚น0.98 B-32.98%
2006-12-31โ‚น1.46 B-30.65%
2005-12-31โ‚น2.11 B150.52%
2004-12-31โ‚น0.84 B-50.63%
2003-12-31โ‚น1.71 B85.03%
2002-12-31โ‚น0.92 B-25.09%
2001-12-31โ‚น1.23 B-17.59%
2000-12-31โ‚น1.49 B197.2%
1999-12-31โ‚น0.50 B39.53%
1998-12-31โ‚น0.36 B-47.75%
1997-12-31โ‚น0.69 B541.34%
1996-12-31โ‚น0.10 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
โ‚น660.20 B 763.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น68.53 B-10.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚น168.51 B 120.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น19.12 B-74.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น244.77 B 220.17%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น151.62 B 98.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
โ‚น150.92 B 97.42%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com